What We Do
Our mission is to accelerate availability and access to innovative therapies that are safer and more effective in the treatment, prevention and follow-up of childhood cancer. We act as a catalyst to stimulate pediatric drug discovery and development and to help ensure accessible, affordable care for survivors of childhood and adolescent cancer, a population expected to reach 500,000 by 2020.